NCT03981679View on ClinicalTrials.gov

Circulating-free DNA Assessment as a Tool to Predict Colorectal Cancer in Subjects With a Positive Fecal Immunoassay.

NACompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

June 5, 2018

Primary Completion Date

January 17, 2020

Study Completion Date

January 17, 2020

Conditions
Colorectal Cancer
Interventions
OTHER

Biological collection

The biological collection will also include samples of blood samples collected before colonoscopy

Trial Locations (1)

34298

ICM - Institut régional du Cancer Montpellier, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT03981679 - Circulating-free DNA Assessment as a Tool to Predict Colorectal Cancer in Subjects With a Positive Fecal Immunoassay. | Biotech Hunter | Biotech Hunter